The topic of this book, the commercialization of public-sector technology, continues to grow in importance in the United States and sirnilarsocieties. The issues involved are relevant to many roles including those of policy makers, managers, patent attorneys, licensing agents, and technical staff members of public technology sources. Institutions increasingly involved in the process include federal and other governmentallaboratories and their related agencies, public universities and their state governments, public and private transfer agents and, of course, all the private recipients of public technology. Scarcely a day goes by without a significant event related to technology transfer and commercialization. The popular business press is regularly carrying articles addressing the issues, explaining new initiatives and describing events of notable success or failure.[l] As an example of current important events, the Technology Reinvestment Project (TRP) is forrnu lating its initiatives totransfer public technology and promote technology-based publiclprivate partnerships as a collaboration between the Advanced Research Projects Agency (ARPA), the National Institute of Standards and Technology (NIST), the National Science Foundation (NSF) the National Aeronautics and Space Administration (NASA), and the Department of Energy, Defense Programs (DOE/DP).

In this book Part I presents first an overview of the ECHORD++ project, with its mission and vision together with a detailed structure of its functionalities and instruments: Experiments, Robotic Innovation Facilities and Public end-user Driven Technology Innovation PDTI. Chapter 1 explains how the project is born, the partners, the different instruments and the new concept of cascade funding projects. This novelty made ECHORD++ a special project along the huge number of research groups and consortia involved in the whole project. So far, it is the European funded project with more research team and partners involved in the robotic field. In Chapter 2, one of the instruments in ECHORD++ is explained in detail: RIF. Robotic innovation facilities are a set of laboratories across Europe funded with the project with the goal of hosting consortia involved in any experiment that have special needs when testing their robotic research. In the chapter the three different and specific RIFs will be described and analyzed. Chapter 3 explains an important instrument in ECHORD++: the Experiments. In this part, a big number of research groups have been involve in short time funded research projects. The chapter explains the management of such Experiments, from the call for participation, the candidate’s selection, the monitoring, reviews and funding for each of the 36 experiments funded for Echord. Chapter 4 is very special because it presents the innovation of funding public end-user driven technology, in particular, robotic technology. The robotic challenge is the key of such an instruments together with the management of the different consortia that participated competitively in the success of the robotic challenge proposed by a public entity, selected also with a very special and innovative process.

A groundbreaking guide to the commercialization of scientific breakthroughs in chemistry, from successful entrepreneurs Chemistry Entrepreneurship is a step-by-step guide that is specifically devoted to understanding what it takes to start and grow a new company in the chemistry sector. Comprehensive in scope, the book covers the various aspects of the creation of a new chemical enterprise including: the protection of the invention, the business plan, the transfer from the research center or university, the financing, the legal setup, the launching of the company and its growth and exit strategies. This hands-on book contains the information needed to help to determine if you have what it takes to be a chemistry entrepreneur, explains how to take an ideas out of the lab and into the real world, reveals how to develop your burgeoning business, and shows how to sustain and grow your business. This much-needed resource also includes interviews with founding scientists who created their own successful chemical companies. This important book: Provides the practical information on how to start a company based on a scientific breakthrough Offers information on the mindset it takes to become, and remain, successful in the marketplace Presents case studies from world-renowned and highly experienced professionals who have successfully started a company Written for chemists in industry, chemists, materials scientists, chemical engineers, Chemistry Entrepreneurshipis a guide for becoming a founder of a successful chemical company.

[This book] meshes a discussion of development issues and processes with four different systems of religious beliefs: Hinduism, Christianity, Islam, and the Baha'i Faith. The authors - each a scientist as well as a person of faith - show how religious belief and personal faith can be deeply motivational and strikingly fruitful in scientific pursuits. Further, they emphasize how their faith has brought them a profound understanding of interconnectedness and compassion, and thus a wider perspective and greater sense of personal meaning to their research. -- Book jacket.

This guide is written for biomedical innovators seeking to improve the lives of patients bytranslating innovative technologies into medical technologies. The contents are focusedprimarily on business principles that have been distilled from hundreds of projects as part ofthe Coulter Foundation's Translational Partners Program and Coulter Translational RewardAwards. To date, the Foundation has funded more than 600 projects, which in the first 11 yearshave raised close to $6 billion in funding.The course Concept to Clinic: Commercializing Innovation (C3i), offered by the NationalInstitutes of Health (NIH), forms the basis of this Guide. This course has helped hundredsof university innovators, engineers, clinicians, and scientists learn how to commercialize thetechnologies they have developed in a very demanding market. The C3i program is basedon the Coulter commercialization process, an approach to biomedical research translationdeveloped and continuously refined by the Foundation in collaboration with its academicpartners across the country.

This book is a good introductory work to nanoparticle technology. It consists of nine complementary chapters that can be read independently. This book covers promising nanoparticles fabrication technologies with a focus on scalable processes. Integration of nanoparticles into 2D and 3D structures are covered in detail. The most promising applications of nanoparticles in the energy, optoelectronic and biomedical sectors are summarized and discussed. Current issues and challenges related to nanoparticles production and utilisation are also discussed in the book. Complete and simple overview of the field Contains practical examples that makes the book also accessible for industrialists, engineers and managers Chapters can be read relatively independently so experienced researchers can go directly to the them of interest Advantages, drawbacks and challenges are described with practical examples

Tetsu Natsume of Sony Computer Science Labs (Sony CSL) has been pioneering technology promotion for a decade. As he seeks marketplace opportunities for ground-breaking research, he plays the role of a Technology Producer -- a role that will be increasingly important as organizations seek optimally efficient and effective applications of basic research. Natsume's task has been greatly facilitated by his association with Sony CSL, a research lab founded by co-author Mario Tokoro. While CSL is owned by SONY, it nevertheless operates almost entirely independently. At CSL, a diverse, cosmopolitan group of talented researchers are free to explore any idea that might one day change the world. Natsume's task is to optimise that process by identifying the best path to the market for the new insights that pour out of CSL. Functioning somewhat like a movie producer, Natsume has blazed a trail for technology promoters the world over. He explains his techniques for overcoming challenges and embracing opportunities. His "10 core principles of technology promotion", which offer the reader an especially valuable framework for moving between the very different worlds of the lab and the marketplace, cover the importance of appropriate timing, speed, commitment and mindset, while being rigorously simple and boldly ambitious. This book is an eye-opening primer for anyone interested in realising and optimising the commercial value of basic research.

A complete overview of bioprinting, from fundamentals and essential topics to recent advances and future applications Additive manufacturing, also known as 3D printing, is one of the most transformative technological processes to emerge in recent decades. Its layer-by-layer construction method can create objects to remarkably precise specifications with minimal waste or energy consumption. Bioprinting, a related process that employs cells and biomaterials instead of man-made substances or industrial materials, has a range of biomedical and chemical uses that make it an exciting and fast-growing area of research. 3D Bioprinting from Lab to Industry offers a cutting-edge overview of this topic, its recent advances, and its future applications. Taking an interdisciplinary approach to a flourishing research field, this book exceeds all existing treatments of the subject in its scope and comprehensiveness. Moving from fundamental principles of the technology to its immense future potential, this is a must-own volume for scientists looking to incorporate this process into their research or product development. 3D Bioprinting from Lab to Industry readers will also find: Treatment of printing parameters, surface topography requirements, and much more Detailed discussion of topics including 5D printing in the medical field, dynamic tuning, the multi-material extrusion approach, and many others A complete account of the bioprinting process, from lab requirements to commercialization 3D Bioprinting from Lab to Industry is ideal for researchers—graduate and post-doctoral scholars—in the areas of materials science, biomedical engineering, chemical engineering, biotechnology, and biochemistry.

In terms of becoming a successful bioentrepreneur, there is still much more to learn. There are many ways to learn the essential fundamentals of entrepreneurship, including through the mistakes of previous businesses and models. Increased knowledge and a better understanding of what works can be derived from these previous failures and mistakes. Additionally, learning from other bioentrepreneurs can help businesses run successfully. By looking deeper into business models, product development, the fundamental concepts of bioentrepreneurship, and the essential characteristics of bioentrepreneurs, one can become better equipped to understand the role of biological sciences in entrepreneurship, specifically the role of product development. Bioentrepreneurship and Transferring Technology Into Product Development provides a comprehensive understanding of the role of biological sciences, specifically in transforming technology into commercial product. This book compiles the theoretical and practical aspects of bioentrepreneurship and discusses the various factors, including creating business plans, acquiring funding, and successful business models. The chapters also cover areas such as small-scale product development, intellectual property rights, funding schemes for start-ups, and new prospective biotechnology product development. This book is essential for bioentrepreneurs, entrepreneurs, product developers, scientists, practitioners, researchers, academicians, and students interested in product development from a biological science perspective.

Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.